Ken Fisher Fisher Asset Management
AUM
$276B
1-Year Est. Return
24.78%
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
1 Year Est. Return
+24.78%
AUM
$276B
AUM Growth
+$24.4B
(+9.7%)
Holding
1,094
Top Buys
| 1 | +$2.89B | |
| 2 | +$383M | |
| 3 | +$299M | |
| 4 |
Microsoft
MSFT
|
+$282M |
| 5 |
Apple
AAPL
|
+$226M |
Top Sells
| 1 | +$1.82B | |
| 2 | +$209M | |
| 3 | +$168M | |
| 4 |
Adobe
ADBE
|
+$118M |
| 5 |
Banco Santander
SAN
|
+$104M |
Sector Composition
| 1 | Technology | 26.4% |
| 2 | Financials | 18.68% |
| 3 | Industrials | 9.33% |
| 4 | Healthcare | 8.68% |
| 5 | Communication Services | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Salesforce
CRM
$248B
| $1.03B | 0.37% |
4,328,230
+101,191
|
|
||
77
Starbucks
SBUX
$96.8B
| $1.02B | 0.37% |
12,025,740
+105,760
|
|
||
78
Illinois Tool Works
ITW
$72.4B
| $952M | 0.34% |
3,650,562
+55,416
|
|
||
79
Alibaba
BABA
$378B
| $946M | 0.34% |
5,293,597
+26,156
|
|
||
80
Vanguard S&P 500 ETF
VOO
$805B
| $945M | 0.34% |
1,543,178
+21,357
|
|
||
81
Deutsche Bank
DB
$69.8B
| $936M | 0.34% |
26,432,006
+960,605
|
|
||
82
Novartis
NVS
$254B
| $928M | 0.34% |
7,239,366
+117,952
|
|
||
83
CSX Corp
CSX
$67.6B
| $918M | 0.33% |
25,855,674
+583,414
|
|
||
84
Carrier Global
CARR
$45.7B
| $904M | 0.33% |
15,139,140
+90,585
|
|
||
85
Royal Bank of Canada
RY
$228B
| $885M | 0.32% |
6,004,866
+281,285
|
|
||
86
Danaher
DHR
$160B
| $866M | 0.31% |
4,369,219
+28,583
|
|
||
87
Invesco QQQ Trust
QQQ
$409B
| $838M | 0.3% |
1,396,483
-52,039
|
|
||
88
Trane Technologies
TT
$89B
| $837M | 0.3% |
1,983,671
-14,769
|
|
||
89
Boston Scientific
BSX
$145B
| $826M | 0.3% |
8,461,025
+755,641
|
|
||
90
Emerson Electric
EMR
$77.2B
| $822M | 0.3% |
6,262,570
+1,069,122
|
|
||
91
Banco Bilbao Vizcaya Argentaria
BBVA
$125B
| $737M | 0.27% |
38,310,215
-3,111,897
|
|
||
92
Lloyds Banking Group
LYG
$75.4B
| $681M | 0.25% |
149,958,264
+1,129,641
|
|
||
93
iShares Global Healthcare ETF
IXJ
$4.42B
| $659M | 0.24% |
7,439,921
+536,127
|
|
||
94
AB InBev
BUD
$119B
| $656M | 0.24% |
11,011,683
+347,750
|
|
||
95
Suncor Energy
SU
$53.2B
| $649M | 0.24% |
15,530,965
+7,158,953
|
|
||
96
Sanofi
SNY
$120B
| $594M | 0.21% |
12,578,746
-556,620
|
|
||
97
Ingersoll Rand
IR
$31.6B
| $574M | 0.21% |
6,942,711
+28,787
|
|
||
98
Novo Nordisk
NVO
$213B
| $573M | 0.21% |
10,322,903
-678,013
|
|
||
99
iShares Global Energy ETF
IXC
$1.9B
| $568M | 0.21% |
13,602,292
+1,068,318
|
|
||
100
Vanguard FTSE Developed Markets ETF
VEA
$187B
| $565M | 0.2% |
9,430,708
+148,111
|
|